HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Topical steroids in the treatment of paronychia induced by the epidermal growth factor receptor inhibitor cetuximab].

AuthorsN Coquart, A Karam, J-P Metges, L Misery
JournalAnnales de dermatologie et de venereologie (Ann Dermatol Venereol) Vol. 137 Issue 4 Pg. 306-7 (Apr 2010) ISSN: 0151-9638 [Print] France
Vernacular TitleIntérêt de la corticothérapie locale dans le traitement des paronychies aseptiques induites par les inhibiteurs de croissance épidermique.
PMID20417368 (Publication Type: Letter)
Chemical References
  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Neoplasm Proteins
  • betamethasone-17,21-dipropionate
  • Betamethasone
  • EGFR protein, human
  • ErbB Receptors
  • Cetuximab
Topics
  • Adenocarcinoma (drug therapy, secondary)
  • Aged
  • Anti-Inflammatory Agents (therapeutic use)
  • Antibodies, Monoclonal (adverse effects, therapeutic use)
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents (adverse effects, therapeutic use)
  • Betamethasone (analogs & derivatives, therapeutic use)
  • Cetuximab
  • Colonic Neoplasms (pathology)
  • ErbB Receptors (antagonists & inhibitors)
  • Female
  • Humans
  • Middle Aged
  • Neoplasm Proteins (antagonists & inhibitors)
  • Paronychia (chemically induced, drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: